MedPath

Prevention of Gestational Diabetes

Not Applicable
Completed
Conditions
Gestational Diabetes
Registration Number
NCT01130012
Lead Sponsor
Kuopio University Hospital
Brief Summary

Gestational diabetes mellitus (GDM)is a major health problem

* growing prevalence of obesity

* the older age of pregnant women

A randomized controlled trial in 54 pregnant voluntary women at high risk for GDM.

* feasibility of an early intervention

* glucose tolerance at weeks 26-28

Detailed Description

1. A 75-g oral glucose tolerance test (OGTT) was performed at weeks 8-12

1. voluntary women in early pregnancy (n=96)

2. 54 high risk mothers were randomized

* lifestyle intervention group (n=27)

* close follow-up (n=27)

2. An OGTT was performed again at weeks 26-28

* the lifestyle intervention group (n=27)

* the close follow-up group (n=27)

* other high-risk women of the early care group (n=42)who were not randomized

3. An OGTT was also performed at weeks 26-28 in two neighboring municipalities

* a standard care high-risk group(n=171)who did not undergo early intervention

4. Primary outcomes

* number of at risk participants developing GDM during pregnancy in the two arms

5. Secondary outcomes

* the effect of intervention on fetal growth

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
440
Inclusion Criteria
  • high risk for gestational diabetes
  • fasting glucose 4.8-5.5 mmol/l and 2-hour glucose of OGTT <7.8 mmol/l
Exclusion Criteria
  • normal glucose tolerance at weeks 8-12
  • gestational diabetes at weeks 8-12

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of at risk participants developing GDM during pregnancy
Secondary Outcome Measures
NameTimeMethod
The effect of intervention on fetal growth
© Copyright 2025. All Rights Reserved by MedPath